Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.

Niina Pitkänen; Armin Finkenstedt; Claudia Lamina; Markus Juonala; Mika Kähönen; Kari-Matti Mäkelä; Benjamin Dieplinger; Andre Viveiros; Andreas Melmer; Isabella Leitner; Lyudmyla Kedenko; Ilkka Seppälä; Jorma S A Viikari; Thomas Mueller; Florian Kronenberg; Bernhard Paulweber; Terho Lehtimäki; Heinz Zoller; Olli T Raitakari; Hans Dieplinger

doi:10.1515/cclm-2021-0837

Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.

Niina Pitkänen, Armin Finkenstedt, Claudia Lamina, Markus Juonala, Mika Kähönen, Kari-Matti Mäkelä, Benjamin Dieplinger, Andre Viveiros, Andreas Melmer, Isabella Leitner, Lyudmyla Kedenko (Co-author), Ilkka Seppälä, Jorma S A Viikari, Thomas Mueller, Florian Kronenberg, Bernhard Paulweber (Co-author), Terho Lehtimäki, Heinz Zoller, Olli T Raitakari, Hans Dieplinger

Department of Internal Medicine I- Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetologylog

Research output: Contribution to journal › Original Article › peer-review

8 Citations (Web of Science)

Original language	English
Pages (from-to)	243-251
Journal	CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume	60
Issue number	2
DOIs	https://doi.org/10.1515/cclm-2021-0837
Publication status	Published - 2022

Keywords

BINDING-PROTEIN AFAMIN
VITAMIN-E
CARDIOVASCULAR RISK
METABOLIC SYNDROME
PLASMA
YOUNG
CELLS
GENE

Access to Document

10.1515/cclm-2021-0837

Cite this

Pitkänen, N., Finkenstedt, A., Lamina, C., Juonala, M., Kähönen, M., Mäkelä, K.-M., Dieplinger, B., Viveiros, A., Melmer, A., Leitner, I., Kedenko, L., Seppälä, I., Viikari, J. S. A., Mueller, T., Kronenberg, F., Paulweber, B., Lehtimäki, T., Zoller, H., Raitakari, O. T., & Dieplinger, H. (2022). Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 60(2), 243-251. https://doi.org/10.1515/cclm-2021-0837

@article{0a9bbec77ec94909bf20d12d90a41e1f,

title = "Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.",

keywords = "BINDING-PROTEIN AFAMIN, VITAMIN-E, CARDIOVASCULAR RISK, METABOLIC SYNDROME, PLASMA, YOUNG, CELLS, GENE",

author = "Niina Pitk{\"a}nen and Armin Finkenstedt and Claudia Lamina and Markus Juonala and Mika K{\"a}h{\"o}nen and Kari-Matti M{\"a}kel{\"a} and Benjamin Dieplinger and Andre Viveiros and Andreas Melmer and Isabella Leitner and Lyudmyla Kedenko and Ilkka Sepp{\"a}l{\"a} and Viikari, {Jorma S A} and Thomas Mueller and Florian Kronenberg and Bernhard Paulweber and Terho Lehtim{\"a}ki and Heinz Zoller and Raitakari, {Olli T} and Hans Dieplinger",

note = "Paulweber; Kedenko: First Department of Internal Medicine I, Paracelsus Medical University Salzburg, Austria. Lehr-KH: Barmherzige Br{\"u}der Linz; Ordensklinikum",

year = "2022",

doi = "10.1515/cclm-2021-0837",

language = "English",

volume = "60",

pages = "243--251",

journal = "CLINICAL CHEMISTRY AND LABORATORY MEDICINE",

issn = "1434-6621",

publisher = "Walter de Gruyter Publishers ",

number = "2",

}

Pitkänen, N, Finkenstedt, A, Lamina, C, Juonala, M, Kähönen, M, Mäkelä, K-M, Dieplinger, B, Viveiros, A, Melmer, A, Leitner, I, Kedenko, L, Seppälä, I, Viikari, JSA, Mueller, T, Kronenberg, F, Paulweber, B, Lehtimäki, T, Zoller, H, Raitakari, OT & Dieplinger, H 2022, 'Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.', CLINICAL CHEMISTRY AND LABORATORY MEDICINE, vol. 60, no. 2, pp. 243-251. https://doi.org/10.1515/cclm-2021-0837

TY - JOUR

T1 - Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.

AU - Pitkänen, Niina

AU - Finkenstedt, Armin

AU - Lamina, Claudia

AU - Juonala, Markus

AU - Kähönen, Mika

AU - Mäkelä, Kari-Matti

AU - Dieplinger, Benjamin

AU - Viveiros, Andre

AU - Melmer, Andreas

AU - Leitner, Isabella

AU - Kedenko, Lyudmyla

AU - Seppälä, Ilkka

AU - Viikari, Jorma S A

AU - Mueller, Thomas

AU - Kronenberg, Florian

AU - Paulweber, Bernhard

AU - Lehtimäki, Terho

AU - Zoller, Heinz

AU - Raitakari, Olli T

AU - Dieplinger, Hans

N1 - Paulweber; Kedenko: First Department of Internal Medicine I, Paracelsus Medical University Salzburg, Austria. Lehr-KH: Barmherzige Brüder Linz; Ordensklinikum

PY - 2022

Y1 - 2022

KW - BINDING-PROTEIN AFAMIN

KW - VITAMIN-E

KW - CARDIOVASCULAR RISK

KW - METABOLIC SYNDROME

KW - PLASMA

KW - YOUNG

KW - CELLS

KW - GENE

U2 - 10.1515/cclm-2021-0837

DO - 10.1515/cclm-2021-0837

M3 - Original Article

C2 - 34850615

SN - 1434-6621

VL - 60

SP - 243

EP - 251

JO - CLINICAL CHEMISTRY AND LABORATORY MEDICINE

JF - CLINICAL CHEMISTRY AND LABORATORY MEDICINE

IS - 2

ER -